[Form 4] Metagenomi Therapeutics, Inc. Insider Trading Activity
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Metagenomi Therapeutics Chief Financial Officer Pamela Wapnick reported new equity awards. She received a grant of 144,000 stock options with an exercise price of $1.34 per share, expiring on March 31, 2036. These options relate to 144,000 shares of common stock.
She was also granted 24,000 shares of common stock in the form of restricted stock units. Twenty-five percent of the RSUs vest on June 5, 2027, with the rest vesting in 12 equal quarterly installments. Her directly owned common stock holdings total 211,375 shares after these grants. The option award vests 25% on April 1, 2027, with the remainder vesting in 36 equal monthly installments.
Positive
- None.
Negative
- None.
Insider Trade Summary
2 transactions reported
Mixed
2 txns
Insider
Wapnick Pamela
Role
Chief Financial Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 144,000 | $0.00 | -- |
| Grant/Award | Common Stock | 24,000 | $0.00 | -- |
Holdings After Transaction:
Stock Option (Right to Buy) — 144,000 shares (Direct);
Common Stock — 211,375 shares (Direct)
Footnotes (1)
- These shares represent restricted stock units ("RSUs"). 25% of the RSUs shall vest on June 5, 2027, with the remainder vesting in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service with the Issuer on each such vesting date. 25% of the shares subject to this option shall vest and become exercisable on April 1, 2027, with the remainder vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service with the Issuer on each such vesting date.
Key Figures
Stock options granted: 144,000 options
Option exercise price: $1.34 per share
Option expiration: March 31, 2036
+4 more
7 metrics
Stock options granted
144,000 options
Grant to CFO on April 1, 2026
Option exercise price
$1.34 per share
Exercise price for 144,000 options
Option expiration
March 31, 2036
Expiry of newly granted options
RSUs granted
24,000 RSUs
Restricted stock units granted to CFO
RSU initial vesting date
June 5, 2027
25% of RSUs vest on this date
Shares held after grant
211,375 shares
Direct common stock holdings after RSU grant
Option vesting start
April 1, 2027
25% of options vest and become exercisable
Key Terms
restricted stock units ("RSUs"), Stock Option (Right to Buy), exercise price, vest, +1 more
5 terms
restricted stock units ("RSUs") financial
"These shares represent restricted stock units ("RSUs"). 25% of the RSUs shall vest on June 5, 2027..."
Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.
Stock Option (Right to Buy) financial
"security_title: "Stock Option (Right to Buy)" for 144000.0000 shares..."
exercise price financial
"conversion_or_exercise_price: "1.3400" per share for the stock option grant..."
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vest financial
"25% of the shares subject to this option shall vest and become exercisable on April 1, 2027..."
A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.
expiration date financial
"expiration_date: "2036-03-31T00:00:00.000Z" for the stock option grant..."
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
